Menu Close

Articles on Biotechnology

Displaying 1 - 20 of 76 articles

Do the benefits of approving a drug before confirming it works outweigh the potential costs? monkeybusinessimages/iStock via Getty Images Plus

The FDA’s big gamble on the new Alzheimer’s drug

The FDA approved Alzheimer's disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don't yet have.
A new study published in the New England Journal of Medicine, discloses the results from phase 1 of Moderna’s COVID-19 vaccine trials. YurolaitsAlbert / Getty Images

Video: An infectious disease expert explains the results from Moderna’s latest vaccine trials

The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
A government-commissioned report estimated that South Australia’s ban on genetically modified crops cost canola growers A$33 million since 2004. Greenpeace/AAP Image

GM crops: to ban or not to ban? That’s not the question

South Australia has lifted its moratorium on GM crops, while Tasmania has extended its ban. But the question should no longer be a simple binary of being "for" or "against" GM technology.

Top contributors

More